Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)

PHASE4RecruitingINTERVENTIONAL

Enrollment

1,990

Participants

Timeline

Start Date

August 6, 2021

Primary Completion Date

May 5, 2025

Study Completion Date

January 1, 2026

Conditions

AnemiaHeart Failure

Interventions

DRUG

Dapagliflozin

Participants will receive dapagliflozin 10 mg once daily

DRUG

Placebo

Participants will receive placebo 10 mg once daily

Trial Locations (1)

RECRUITING

Xiangtan Central Hospital, Xiangtan

All Listed Sponsors

collaborator

Second Xiangya Hospital of Central South University

OTHER

collaborator

ZhuZhou Central Hospital

OTHER

lead

Xiangtan Central Hospital

OTHER